Modulation of structured polypeptide specificity
US10118947B2 · kind B2 · utility
17Cited by
0References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 11, 2014 |
| Grant date | Nov 6, 2018 |
| Priority date | — |
| Expiry date | Apr 11, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N9/6445
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention describes peptide ligands specific for human plasma Kallikrein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.